Company intelligence / Profile preview
PathoBlock Therapeutics
Berlin, Berlin, Germanypathoblock.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
PathoBlock Therapeutics is a clinical-stage biotechnology company dedicated to combating antimicrobial resistance (AMR) through an innovative pathoblocking approach. Instead of directly killing bacteria like traditional antibiotics, the company's therapeutics block the pathogenicity and adhesion of bacteria to human cells, allowing the host's immune system to clear the disarmed pathogens. PathoBlock's lead candidate, PB-TX-01, is a topical powder formulation containing elfucose and d-galactose designed to treat chronic wounds colonized by Pseudomonas aeruginosa. The company is currently evaluating PB-TX-01 in a Phase II clinical trial in Germany to assess its safety, tolerability, and efficacy in improving wound healing.
- Therapeutic areas
- Infectious DiseasesDermatology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Asklepios Klinik Wandsbek
Beyond the preview
Go deeper on PathoBlock Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PathoBlock Therapeutics.